Impli

Empowering Women’s Health: Impli x Bayer Partnership 🚀 We are beyond excited to share that Impli is partnering with Bayer to drive real innovation in women’s health! Together, we’re committed to transforming how women understand and manage their hormonal health with our cutting-edge, real-time hormone monitoring device. 🌱 Hormones play a critical role in every stage of a woman’s life, influencing everything from fertility and reproductive health to stress, sleep, and overall well-being. Yet, understanding these hormonal shifts has always been challenging. That’s why our partnership with Bayer is so significant—it allows us to bring life-changing technology to women, helping them take control of their health journeys with precision and confidence. 🔬💡 At Impli, we believe that real-time hormone monitoring has the power to make fertility treatments more accessible, safer, and more successful. But it doesn’t stop there. This innovation holds potential for improving everyday health management, empowering women to make smarter decisions about their bodies. 💪 We are proud to be on this journey with Bayer, a global leader committed to advancing health care, and together we will push the boundaries of what’s possible in women’s health. 🎉 #WomensHealth #Impli #Bayer #HormonalHealth #Fertility #InnovationForWomen #HealthTech #DigitalHealth #Empowerment #PrecisionHealth #HealthcareInnovation

🎉 Congratulations to the First-Ever SiS Solve Pitch Event Winner…   Anna Luisa Schaffgotsch, Founder of Impli! 🎉   Anna Luisa took to the stage at SiS: Women's Health London 2024 with her cutting-edge implantable technology, Impli    👩💻 Pitching alongside 7 other successful women's health founders, the audience was captivated by Impli's ability to make health data more accessible and secure through it's groundbreaking technologies. 𝗖𝗼𝗻𝗴𝗿𝗮𝘁𝘂𝗹𝗮𝘁𝗶𝗼𝗻𝘀 𝗮𝗴𝗮𝗶𝗻 𝘁𝗼 𝗔𝗻𝗻𝗮 𝗟𝘂𝗶𝘀𝗮 𝗮𝗻𝗱 𝘁𝗵𝗲 𝗲𝗻𝘁𝗶𝗿𝗲 𝗜𝗺𝗽𝗹𝗶 𝘁𝗲𝗮𝗺! 👏   We know you'll enjoy the bubbles after the long wait 🥂👶 and look forward to seeing the future of healthcare innovation led by your vision. Check out Impli's work here - https://www.impli.org/   #SiSSolve #SiSLondon2024 #womenshealth

Venture Leaders Medtech 2024 kicked-off their Boston roadshow. In November, the ten Venture Leaders will represent Switzerland in Boston, USA, pitching their solutions and connecting with investors, experts, and industry leaders. They met at the startup space to introduce themselves and showcased their innovations in an online pitch session. https://lnkd.in/dVTNpRQa Meet the ten Venture Leaders Medtech 2024: Waldemar Hoffmann | Apersys AG: Overcoming organ shortage. www.apersys.com Eashan Saikia | Aseptuva: Fighting secondary infections in critically-ill patients. www.aseptuva.com Markus Windolf | BIOS Medical: Implanted BIOSensors to restore life. https://lnkd.in/e86sBVeb Marie-Agnès Doucey | Calico Biosystems: Predicting life-changing drugs for cancer. www.calicobiosystems.com David Sachs | CITUS: Enabling fibrosis characterization by mechanics. https://www.citus-ag.com/ Heath Hartle | Impli: First Real-Time Hormone Monitoring Device for IVF. https://www.impli.org/ André Jaun | Metadvice: Accelerating Personalised and Complex Disease Care. https://www.metadvice.com Greta Preatoni | MYNERVA: Reduce Pain and falls through AI-driven neurostimulation. https://lnkd.in/eeBBczDU Roberta Gatta | OncoSwab: Simplifying Lung Cancer Detection. www.oncoswab.com Michael Rottmann | OneTwenty.ai: Revolutionizing Diabetes Care and the live of 500m. https://onetwenty.ai “Preparing for this roadshow for the 18th year is a tribute to the quality of innovation and the startups that have been part of this journey,” shared Stefan Steiner, co-managing director of Venturelab. “I can’t wait to join this new edition and support the team in its international expansion.” Venture Leaders Medtech is organized by Venturelab and Swissnex in Boston and New York and supported by EPFL, ETH Zürich, Hansjörg Wyss, Health Innovation Hub Aargau, Kellerhals Carrard, Etat de Vaud, Kanton Zürich, and VISCHER. #VLeadersMedtech #SwissStartups

🌟 **Impli is thrilled to announce that we've been selected as a Venture Leader Medtech 2024!** 🌟 We're honored to join an amazing group of 10 Swiss medtech startups that will be embarking on an investor and business development roadshow to Boston, USA, from November 4th to 8th. As part of the Swiss National Startup Team, we’re excited to showcase our innovation: the **first real-time hormone monitoring device for IVF**. This recognition not only highlights our commitment to revolutionizing hormone monitoring but also reaffirms Switzerland’s position at the forefront of medtech innovation. We're grateful to Venturelab, Swissnex in Boston and New York, and all the incredible supporters and partners for this opportunity. Meet our fellow Venture Leaders Medtech 2024 and discover their groundbreaking solutions: https://lnkd.in/em9G--ap Thank you for supporting us on this incredible journey! Stay tuned as we continue to push the boundaries of medtech and make IVF more effective and accessible worldwide. 🌍💡 Learn more about the Venture Leaders Medtech program: https://lnkd.in/ez4ZcNz4 #VentureLeaders #Medtech #Innovation #Startups #Boston #IVF #Healthcare #SwissInnovation #HormoneMonitoring

Proud to present: the Venture Leaders Medtech 2024, representing the best of swiss medical technology on their investor and business development roadshow to Boston, USA. Meet the winners: https://lnkd.in/em9G--ap Apersys AG: Overcoming organ shortage www.apersys.com Aseptuva: Fighting secondary infections in critically-ill patients www.aseptuva.com BIOS Medical: Implanted BIOSensors to restore life https://lnkd.in/e86sBVeb Calico Biosystems: Predicting life-changing drugs for cancer www.calicobiosystems.com Citus: Enabling fibrosis characterization by mechanics https://www.citus-ag.com/ Impli: First Real-Time Hormone Monitoring Device for IVF https://www.impli.org/ Metadvice: Accelerating Personalised and Complex Disease Care https://www.metadvice.com MYNERVA: Reduce Pain and falls through AI-driven neurostimulation https://lnkd.in/eeBBczDU OncoSwab: Simplifying Lung Cancer Detection www.oncoswab.com OneTwenty.ai: Revolutionizing Diabetes Care and the live of 500m https://onetwenty.ai About: The expert jury selected the 10 Venture Leaders Medtech 2024, who will travel to Boston from November 4th to 8th as part of the Swiss National Startup Team. The new team is again a testament to Switzerland’s leadership in medtech innovation. Venture Leaders Medtech is organized by Venturelab and Swissnex in Boston and New York and supported by EPFL, ETH Zürich, Hansjörg Wyss, Health Innovation Hub Aargau, Kellerhals Carrard Startup & VC Desk, Canton de Vaud (Innovaud / Vaud Promotion), Kanton Zürich, and VISCHER. Learn more at: https://lnkd.in/ez4ZcNz4 #VLeadersMedtech #SwissStartups

🧪Hormones are critical indicators of a person's mental, physical, and reproductive health. Despite their importance, drawing blood is the only method to access this information. Providing only snapshots of hormone data, and at an inefficient and costly manner, hormone health remains an untapped resource in healthcare. 🎉We're thrilled to announce our collaboration with CSEM and Yalosys AG with the help of Innosuisse on the development of CERES, an innovative biosensor technology designed for continuous and accurate hormone monitoring. ⭐️This breakthrough will unlock countless opportunities to enhance fertility management, offering a clearer and more dynamic approach to women's reproductive health. We are beyond excited for the future of healthcare innovation! #HealthcareInnovation #Biosensors #WomenHealth #FertilityManagement

🌟Hormones allow women to experience and navigate various stages of life with balance and health. Women’s physiology is profoundly influenced by hormones. Thanks to these hormonal processes, women can maintain overall well-being and achieve reproductive health. Understanding and monitoring these hormones can empower women to take control of their health and make informed decisions about their reproductive journey. 💪💖 At CSEM, we are proud to join forces with Impli and Yalosys AG in the development of CERES, an innovative biosensor designed for accurate and continuous monitoring of crucial hormones. This advancement can significantly enhance fertility management strategies, offering a clearer picture of a woman's reproductive health. 🌟🔬 Anna Luisa Schaffgotsch Luigi Calabrese, PhD Gilles Weder Loïc . Bradley Petkus Heath Hartle #FertilityInnovation #Biosensor #CERES #IVFSolutions #HormoneMonitoring #HealthcareTech #WomensHealth #FemTech #lovemyjob

A huge thank you to everyone who visited our poster exhibition, attended our session and engaged with us at ESHRE 2024. We’re inspired by incredible discussions and collaborations. Stay connected with us and transform the future of IVF.#ESHRE2024 #EventWrapUp #FutureOfIVF

We’re live at European Society of Human Reproduction and Embryology (ESHRE)'s 40th Annual Meeting! Follow along as we share real time updates, photos, and highlights from the event. #ESHRE2024 #Biotech #IVFInnovation

Looking forward to seeing Simon Hanassab lecture on the transformative role of AI on reproductive health at ESHRE’s 40th anniversary conference. As a current PhD candidate at Imperial College, Simon will be sharing groundbreaking insights on how AI is revolutionizing IVF treatments and outcomes. As we continue to innovate with our implantable hormone monitoring devices, we are particularly excited to learn from his expertise and explore the synergies between AI and our cutting-edge technology. Join us in attending this session to understand how AI is shaping the future of fertility treatment. #ESHRE2024 #Biotech #IVFInnovation #AIinHealthcare #FutureofIVF